The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses

Journal of Clinical Investigation

Volumn 116, Issue 4, 2006, Pages 1092-1101

  Amedei, Amedeo ^a   Cappon, Andrea ^b,c   Codolo, Gaia ^b,c   Cabrelle, Anna ^b,c   Polenghi, Alessandra ^b,c   Benagiano, Marisa ^a   Tasca, Elisabetta ^c   Azzurri, Annalisa ^a   D'Elios, Mario Milco ^a,d   Prete, Gianfranco Del ^a,d   De Bernard, Marina ^b,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR 2;

ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; MONOCYTE; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH MUCOSA; T LYMPHOCYTE; TH1 CELL; UPREGULATION;

ADULT; ALLERGENS; ANTIGENS, CD4; BACTERIAL PROTEINS; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; GENES, MHC CLASS II; GRANULOCYTES; HELICOBACTER PYLORI; HUMANS; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-23; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKINS; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; PHENOTYPE; TH1 CELLS; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33645524169     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI27177     Document Type: Article

References (41)

1. Marshall, B.J., and Warren, J.R. 1984. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1:1311-1315.
2. Blaser, M.J., and Atherton, J.C. 2004. Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 113:321-323. doi:10.1172/JCI200420925.
3. Goodwin, C.S. 1997. Helicobacter pylori gastritis, peptic ulcer and gastric cancer: clinical and molecular aspects. Clin. Infect. Dis. 25:1017-1019.
4. Parsonnet, J., et al. 1994. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330:1267-1271.
5. Dixon, M.F., Genta, R.M., Yardley, J.H., and Correa, P. 1996. Classification and grading of gastritis. Am. J. Surg. Pathol. 20:1161-1181.
6. D'Elios, M.M., et al. 1997. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:962-967.
7. Reyrat, J.M., et al. 1999. Towards deciphering the Helicobacter pylori cytotoxin. Mol. Microbiol. 34:197-204.
8. Montecucco, C., and de Bernard, M. 2003. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect. 5:715-721.
9. Molinari, M., et al. 1998. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med. 187:135-140.
10. Boncristiano, M., et al. 2003. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J. Exp. Med. 198:1887-1897.
11. Evans, D.J., Jr., et al. 1995. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect. Immun. 63:2213-2220.
12. Montemurro, P., et al. 2001. Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells. J. Infect. Dis. 183:1055-1062.
13. Telford, J.L., et al. 1994. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med. 179:1653-1658.
14. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptative immunity. Nat. Rev. Immunol. 3:133-146.
15. Snijders, A., et al. 1996. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156:1207-1212.
16. Oppmann, B., et al. 2000. Novel p19 engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 13:715-725.
17. Takeda, K., Kaisho, T., and Akira, S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
18. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145.
19. Alexopoulou, L., Holt, A.C., Medzhitov, R., and Flavell, R.A. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature. 413:732-738.
20. Medzhitov, R., Preston-Hurlburt, P., and Janeway, C.A., Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:394-397.
21. Poltorak, A., et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:2085-2088.
22. Hemmi, H., et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature. 408:740-745.
23. Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., and Lanzavecchia, A. 2005. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6:769-776.
24. Schindler, U., and Baichwal, V.R. 1994. Three NF-kappaB binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol. Cell. Biol. 14:5820-5831.
25. Jensen, L.E., and Whitehead, A.S. 2003. ELAM-1/ E-selectin promoter contains an inducible AP-1/ CREB site and is not NF-κB-specific. Biotechniques. 35:54-58.
26. Akira, S., and Taheda, K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511.
27. Del Prete, G., et al. 1993. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur. J. Immunol. 23:1445-1449.
28. Del Prete, G., De Carli, M., Ricci, M., and Romagnani, S. 1991. Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: the help of Th1 clones is limited by their cytolytic capacity. J. Exp. Med. 174:809-813.
29. Grant, R.A., Filman, D.J., Finkel, S.E., Kolter, R., and Hogle, J.M. 1998. The crystal structure of Dps, a ferritin homolog that binds and protects DNA. Nat. Struct. Biol. 5:294-303.
30. Tonello, F., et al. 1999. The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure. Mol. Microbiol. 34:238-246.
31. Tomb, J.-F., et al. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 388:539-547.
32. Zanotti, G., et al. 2002. Structure of the neutrophil-activating protein from Helicobacter pylori. J. Mol. Biol. 323:125-130.
33. Bancherau, J., and Steinman, R.M. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
34. Reis e Sousa, C., Sher, A., and Kaye, P. 1999. The role of dendritic cells in the induction and regulation of immunity to microbial infection. Curr. Opin. Immunol. 11:392-399.
35. Dixon, G.L., et al. 2001. Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria. Infect. Immun. 69:4351-4357.
36. Kranzer, K., et al. 2004. Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori. Infect. Immun. 72:4416-4423.
37. Dundon, W.G., Polenghi, A., Del Guidice, G., Rappuoli, R., and Montecucco, C. 2001. Neutrophil-activating protein (HP-NAP) versus ferritin (Pfr): comparison of synthesis in Helicobacter pylori. FEMS Microbiol. Lett. 199:143-149.
38. Montemurro, P., et al. 2001. Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells. J. Infect. Dis. 183:1055-1062.
39. 2+], and arachidonic acid release. J. Immunol. 142:1652-1660.
40. + T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat. Med. 10:406-410.
41. Del Prete, G., et al. 1991. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88:346-350.